Renaissance Acquisition Holdings, LLC, a portfolio company of private equity firm RoundTable Healthcare Partners, has entered into a definitive agreement to sell its topical pharmaceutical business to Mylan for $950 million in cash, plus additional contingent payments of as much as $50 million. The Topical Division is a specialty pharmaceutical business focused on the manufacture, development, sales and marketing of branded and generic topical pharmaceutical products. RoundTable started Renai...